Based on these supporting evidences, serum YKL-40 has been evaluated as a noninvasive marker of fibrotic liver diseases, including alcoholic liver disease [20], non-alcoholic fatty liver disease [21] and chronic hepatitis C-induced liver fibrosis [22, 23]. The gene discussed is CHI3L1; the disease is chronic hepatitis C virus infection.